4584 Kidswell Bio
- 141
- +4+2.92%
Kidswell Bio News
Lear, GTS, and other emerging markets ratings list.
"Ichiyoshi" <9270> Valueness A stationary buy "Mizuho" <4579> Laquaoria buy stationary <4584> GTS buy stationary *The above ratings of each company are as of 07/22 according to our confirmation.
Dai, MFS, and other emerging markets follow the 5% rule.
<151A> Deere & Co Guardian Capital Singapore Private Limited (Gordian Capital Singapore Private Limited) shareholding ratio 5.05% → 3.96%, report due date 07/09/2024 <196A> MFS Gordian Capital Singapore Private Limited (Gordian Capital Singapore Private Limited)
Insider decrases its stake in Kidswell Bio(4584.JP) to 24.58%
On Jul 17, ハイツ・キャピタル・マネジメント・インク submitted the Change Report to Ministry of Finance. The report shows that ハイツ・キャピタル・マネジメント・インク decreased their holdings in $Kidswell Bio(4584.JP)$, with their
KidsWell Bio, ELEMNTS, etc.
<186A> Astroscale Holdings Inc. Ace Start shareholding: 5.78%, report obligation start date: 2024/06/05. <186A> Astroscale Holdings Inc. INCJ shareholding: 15.08%, report obligation start date: 2024/06/05. <186A> Astroscale Holdings Inc. Okada Mitsunobu shareholding: 2%.
Insider decrases its stake in Kidswell Bio(4584.JP) to 26.08%
On Jul 10, ハイツ・キャピタル・マネジメント・インク submitted the Change Report to Ministry of Finance. The report shows that ハイツ・キャピタル・マネジメント・インク decreased their holdings in $Kidswell Bio(4584.JP)$, with their
Kidswell Bio: Interim report
Kidswell Bio: Financial Report - The 24th Term (2023/04/01 - 2024/03/31)
Stocks that moved the day before part 2: IseChemical Industrial, AHC Group, DI System, etc.
Stock name <code>19-day closing price ⇒ Previous day comparison K&O Energy Group <1663> 3510 -285 Negative view also on Ise Chemical's stock price decline. Shiseido <4911> 4681 -234 Also viewed negatively due to Bain survey showing China's wealthy restraint in buying. Trend Micro <4704> 6359 -304 Cautious of easing supply and demand in the near term due to the end of share buybacks. Zensho Holdings <7550> 5903 -214 No new material observed, but dislike of slowness of return in the low range.
Emerging markets stock digest: GoodPatch hits all-time low since listing, JRC has risen significantly for 4 consecutive days.
<4592> Sanbio fell for the 9th consecutive time to 998. It was reported that the Ministry of Health will hold a meeting of the Pharmaceuticals and Food Sanitation Council's Regenerative Medicine and Biotechnology Division from 6:00 p.m. on the 19th. Sanbio's SB623 development product is included in the discussion items as "approval or non-approval of manufacturing and sales approval, conditions and deadlines for approval, and whether or not to designate a re-examination period". There is a possibility that manufacturing and sales approval will be granted at the same meeting, leading to a potential increase in buying.
Hot stocks digest (morning session): FP Partner, FujitaKan, Mitsubishi Motors, etc.
KOKUSAI<6525>: ¥4800 (-¥200), a significant drop for the fourth consecutive day. They held their first IR Day since listing on the previous day, with updates on market outlook details and medium-term targets. Their plans for the next 3-4 years are to reach over WFE 120 billion (previously ¥110-120 billion) and ¥330 billion in revenue (previously ¥300-330 billion). Surprises were limited, and the outlook was already positive, which may cause a sense of exasperation.
Kaiohm - a significant rebound, reached a basic agreement on business partnership with Kids Well Bio for the development of biosimilar pharmaceuticals.
Significantly rebounded. Kidswell Bio <4584> announced the conclusion of a basic agreement on business partnership related to the development of biosimilar pharmaceuticals. Both companies will share their experience and know-how in the development of biopharmaceuticals they hold, as well as sharing the costs related to development investment. The revenue obtained by transferring or licensing cell strains and manufacturing processes developed through the cooperation of both companies to pharmaceutical companies will be profit shared by both companies, aiming to establish a new source of revenue.
Supported by steadfastness and low long-term US interest rates, among other factors.
[Emerging Market Individual Stock Strategy] Today's emerging market is expected to show a solid development. In the U.S. stock market on the 18th, the Dow Jones Industrial Average continued to rise, up 56.76 dollars (+0.15%) to 38,834.86 dollars. The result of May's U.S. retail sales justified the interest rate cut, which supported stock prices. At the same time, concerns about the economy have also spread and the market has remained sluggish. With the decline of long-term interest rates, high-tech stocks remained firm all day. The Nasdaq hit a record high for the seventh consecutive business day. Today, the emerging market is a buy.
Kids' Bio, Cringle, and others.
<2997> Implementation of the Storage King shareholder benefits and introduction of shareholder benefit system <4563> Ange's 44th new share subscription right (with exercise price adjustment clause) Large-scale exercise of subscription rights, 3.9 million shares delivered from the 18th <4584> Kids Bio Caiohm Biosciences <4583> Signed a business alliance agreement for the joint development of new biosimilars <4882> Perseus large-scale exercise of the 28th new share subscription right (with exercise price adjustment clause), 370,200 shares delivered from the 14th.
Supported by steady and weak incline in U.S. long-term interest rates, but the upside potential is heavy.
[Emerging markets individual stock strategy] Today's emerging markets are expected to show a strong performance. In the US stock market on the 11th, the Dow Jones Industrial Average fell by 120.62 dollars (-0.31%) to 38,747.42 dollars, and sold off in anticipation of the release of the Federal Open Market Committee (FOMC) and Consumer Price Index (CPI). Concerns about commercial real estate, among other things, and the bank sector weighing down the Dow all day, causing it to perform weakly. The Nasdaq turned upside down, buoyed by the rise of mobile device maker Apple (AAPL).
Kids Bio, GENDA, and others.
A-reit etf is selling its real estate (land and buildings) in Osaka City, Osaka Prefecture under <2998> Clearal sales. <4584> In cooperation with the Bio-Logic Research and Training Center (BCRET), a general incorporated association that deals with education related to the development, manufacturing, and analysis of the kids/biobehavioral field, we have entered into a commissioned contract to strengthen the partnership. <9166> Genda has established a shareholder benefit scheme and its subsidiary, Kiddleton, Inc. (USA), operates the Mini-roku business.
Kidswell Bio: Confirmation letter
Kidswell Bio: Corrected Securities Report - 23rd period (April 1, 2022 - March 31, 2023)
KIDSWELL BIO: Notice regarding publication of consolidated earnings forecasts due to the transition to consolidated financial results
KIDSWELL BIO: Supplementary explanation material for the financial results report for the fiscal year ending 2024/3
KIDSWELL BIO: Summary of financial results for the fiscal year ending 2024/3 [Japanese GAAP] (unconsolidated)
Analysis
Price Target
No Data
